UNC’s Institute of Global Health and Infectious Diseases Director Myron Cohen, MD, is the lead investigator of a study recently published in the Journal of the American Medical Association (JAMA) that shows bamlanivimab monotherapy reduced the incidence of infection in skilled nursing homes and assisted living facilities with high risk of SARS-CoV-2 exposure. The randomized phase 3 clinical trial … Continued

  Eli Lilly today released results of a clinical trial that found bamlanivimab, a monoclonal antibody, significantly reduced the risk of contracting COVID-19 among residents and staff of long-term care facilities. The Phase 3 trial was conducted in partnership with the NIH’s National Institute of Allergy and Infectious Diseases and the COVID-19 Prevention Network (CoVPN). … Continued

Presented by Larry Corey, MD Past President and Director, Professor of Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center Professor, Medicine and Laboratory Medicine, University of Washington Corey is an internationally renowned expert in virology, immunology and vaccine development. His research focuses on herpes viruses, HIV, the novel coronavirus, and other viral infections, … Continued

  The National Institutes of Health has awarded University of North Carolina’s Institute for Global Health & Infectious Diseases nearly $25 million over seven years to continue operating its Global HIV Clinical Trials Unit, or CTU. The new funding will support HIV treatment and prevention in adults, children and pregnant women at four research sites … Continued

Study led by female investigators enrolled women living with HIV in sub-Saharan Africa A long-acting injectable drug, cabotegravir, is safe and more effective than a daily pill in preventing HIV acquisition, according to results from a study of 3,127 cisgender women in sub-Saharan Africa. Led by UNC researchers beginning in November 2017, the study showed … Continued

The National Institutes of Health has awarded Myron Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and FHI 360 $9.2 million to support research through the new COVID Prevention Network (CoVPN). The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has formed the network to better … Continued

  Large-scale study funded by NIAID and ViiV Healthcare halted early after cabotegravir, dosed every two months, shows higher efficacy than daily oral pill.   The decades-long search for a vaccine to prevent HIV reached a new milestone as results from HPTN 083, a global large-scale study, show that the long-acting drug cabotegravir (CAB LA) … Continued

Myron Cohen, MD, Yeargan-Bate Distinguished Professor of medicine, microbiology, and immunology and epidemiology and director of the Institute for Global Health and Infectious Diseases, and Wesley Fowler, MD, associate dean for medical alumni affairs and professor of obstetrics and gynecology,and have been inducted into the Order of the Golden Fleece, UNC’s oldest and most prestigious … Continued

Dr. Cohen talks about the rules to fighting infections during the Lancet-CAMS health summit.   Myron Cohen, chief of UNC’s Division of Infectious Diseases and director of the Institute for Global Health and Infectious Diseases, visited with UNC Project-China staff and partners in October 2016, making presentations in three cities and serving as keynote speaker … Continued